SEC Form 4 · accession 0000899243-18-029127
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Molineaux
Officer — PRESIDENT AND CEO · Director
Period of report
Nov 14, 2018
Accepted (ET)
Nov 16, 2018 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 14, 2018 | G | 6,476 | $0.00 | D | 408,574 | I | By Trust |
| Common StockF3 | holding | — | — | — | 2,500 | D | ||
| Common Stock | holding | — | — | — | 2,500 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares transferred to the Reporting Person's children. The securities owned by the children are not beneficially owned by the Reporting Person.
- F2Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee, including 44,860 shares transferred from the Reporting Person to the Trust on April 10, 2018.
- F3Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 8, 2018.